Qiagen (NYSE:QGEN) Holdings Raised by Public Sector Pension Investment Board

Public Sector Pension Investment Board boosted its stake in Qiagen (NYSE:QGEN) by 23.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 115,032 shares of the company’s stock after buying an additional 22,039 shares during the period. Public Sector Pension Investment Board owned 0.05% of Qiagen worth $5,232,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. GAMMA Investing LLC grew its holdings in shares of Qiagen by 806.5% in the 3rd quarter. GAMMA Investing LLC now owns 562 shares of the company’s stock worth $26,000 after acquiring an additional 500 shares during the last quarter. Toronto Dominion Bank acquired a new position in shares of Qiagen in the 2nd quarter valued at $27,000. Massmutual Trust Co. FSB ADV increased its stake in Qiagen by 39.8% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 853 shares of the company’s stock worth $39,000 after purchasing an additional 243 shares in the last quarter. CWM LLC raised its holdings in Qiagen by 12.0% during the 2nd quarter. CWM LLC now owns 2,505 shares of the company’s stock worth $103,000 after buying an additional 269 shares during the period. Finally, Headlands Technologies LLC lifted its stake in Qiagen by 396.6% during the second quarter. Headlands Technologies LLC now owns 2,741 shares of the company’s stock valued at $113,000 after buying an additional 2,189 shares in the last quarter. Institutional investors and hedge funds own 70.00% of the company’s stock.

Qiagen Trading Down 0.7 %

Qiagen stock opened at $43.43 on Monday. The company has a quick ratio of 1.89, a current ratio of 2.17 and a debt-to-equity ratio of 0.39. Qiagen has a 12 month low of $39.03 and a 12 month high of $47.44. The company’s fifty day simple moving average is $43.22 and its 200-day simple moving average is $43.70. The stock has a market cap of $9.91 billion, a P/E ratio of 111.36, a P/E/G ratio of 3.37 and a beta of 0.41.

Wall Street Analyst Weigh In

QGEN has been the topic of a number of recent analyst reports. HSBC lowered shares of Qiagen from a “buy” rating to a “hold” rating and set a $49.00 price target on the stock. in a report on Thursday, October 17th. Hsbc Global Res upgraded Qiagen to a “hold” rating in a report on Thursday, October 17th. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $50.88.

Qiagen Company Profile

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.